Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Long-Term Deferred Tax (2023 - 2024)

Updated

Impact Biomedical (IBO) reported Long-Term Deferred Tax of $33,000 for Q4 2024, compared with -$1.01 million a year earlier.

Analysis

Impact Biomedical (IBO) Long-Term Deferred Tax (2023 - 2024) Analysis & Trends

  • By year, Long-Term Deferred Tax came in at -$1.01 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 33,000.00
Dec 31, 2023 -1.01 Mn
API Access

Impact Biomedical Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=IBO&period=max&api_key=YOUR_API_KEY